Relating to the nonsubstantive revision of the health and human services laws governing the Health and Human Services Commission, Medicaid, and other social services.
Relating to the reimbursement of prescription drugs under Medicaid and the child health plan program.
Relating to written notification provided by drug manufacturers regarding the cause of generic insulin prescription drug unavailability.
Relating to prescription drug benefits under Medicaid and the child health plan program.
Relating to written notification provided by drug manufacturers regarding the cause of generic or biosimilar insulin prescription drug unavailability.
Relating to the powers and duties of the Health and Human Services Commission and the transfer to the commission of certain powers and duties from the Department of Family and Protective Services.
Relating to the powers and duties of the Health and Human Services Commission and the transfer to the commission of certain powers and duties from the Department of Family and Protective Services.
Relating to the application of prescription drug price rebates to reduce health benefit plan enrollee cost sharing.
Relating to the consolidation of ombudsman programs administered by the Health and Human Services Commission.
Relating to the submission of certain reports by the Health and Human Services Commission.